Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index - Erion, M D; Cable, E E; Ito, B R; Jiang, H; Fujitaki, J M; Finn, P D; Zhang, B H; Hou, J; Boyer, S H; van Poelje, P D; Linemeyer, D L (Proc Natl Acad Sci USA, 2007)